Ad5 vector vaccine targeting E6/7 tumor associated antigen, (E.C7 cell line) (Etubics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameAd5 vector vaccine targeting E6/7 tumor associated antigen, (E.C7 cell line) (Etubics)
Drug Alias Nameadenovirus vector E2b-deleted therapeutic vaccine (E.C7 cell line) (Etubics)
ClassificationVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProtein E7 modulatorsProtein E6 modulators
TargetsProtein E7Protein E6
Therapy Area/IndicationsHead and Neck Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEtubics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEtubics Corp
Active IndicationsN/A
Inactive IndicationsHead and Neck Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A